A review on emerging targeted therapies for the management of metastatic colorectal cancers

被引：0
|
作者：
Rohitas Deshmukh
Mahendra Prajapati
Ranjit K. Harwansh
机构：
[1] GLA University,Institute of Pharmaceutical Research
来源：
Medical Oncology | / 40卷
关键词：
Colorectal cancer; Median overall survival; EGFR; VEGF; KRAS; Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Emerging targeted therapies for melanoma treatment (Review)
    Russo, Angela
    Ficili, Bartolomea
    Candido, Saverio
    Pezzino, Franca Maria
    Guarneri, Claudio
    Biondi, Antonio
    Travali, Salvatore
    McCubrey, James A.
    Spandidos, Demetrios A.
    Libra, Massimo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 516 - 524
  • [22] Targeted Therapies in Colorectal Cancer: Complications and Management
    Sundermeyer, Mark L.
    Lessin, Stuart R.
    Meropol, Neal J.
    CURRENT COLORECTAL CANCER REPORTS, 2006, 2 (03) : 125 - 133
  • [23] Integrating Targeted Therapies in the Management of Head and Neck Cancers
    Burtness, Barbara
    CANCER JOURNAL, 2022, 28 (05): : 329 - 330
  • [24] Molecular Testing and Targeted Therapies in Hepatobiliary Cancers A Review
    Tsilimigras, Diamantis I.
    Kurzrock, Razelle
    Pawlik, Timothy M.
    JAMA SURGERY, 2025,
  • [25] Emerging therapies for rare cutaneous cancers: A systematic review
    Garcia, Andrew
    Nelson, Kamaria
    Patel, Vishal
    CANCER TREATMENT REVIEWS, 2021, 100
  • [26] Targeted therapies for metastatic colorectal cancer (mCRC): A systematic review of cost-effectiveness (CE).
    Bentley, Tanya G.
    Broder, Michael Samuel
    Das, Lopamudra
    Ortendahl, Jesse
    Su, Yun
    Wagner, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [27] Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers
    Demir, Tarik
    Moloney, Carolyn
    Mahalingam, Devalingam
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 199
  • [28] More is less—combining targeted therapies in metastatic colorectal cancer
    Cornelis J. A. Punt
    Jolien Tol
    Nature Reviews Clinical Oncology, 2009, 6 : 731 - 733
  • [29] An appraisal of emerging second line therapies for metastatic colorectal cancer
    Smolenschi, Cristina
    Perret, Audrey
    Dall'Armellina, Francois
    Boige, Valerie
    Malka, David
    Hollebecque, Antoine
    Ducreux, Michel
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (02) : 165 - 179
  • [30] The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy
    Demols, Anne
    Bucalau, Ana-Maria
    Mans, Laura
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (04) : 403 - 411
12345